Hoshen, Moshe B., Arriel Benis, Katherine M. Keyes, and Helga Zoëga. “Stimulant Use for ADHD and Relative Age in Class among Children in Israel.” Pharmacoepidemiology and Drug Safety (early view; online first).
Diagnosis of children with attention-deficit/hyperactivity disorder (ADHD) is increasing. The present study sought to identify characteristics and medication treatment patterns of children with ADHD and compare them by relative age in class, sex, ethnicity, family size, sibling order, and other socioeconomic status, as well as find trends in disparity of pharmacotherapy. This study was based on data from 1 013 149 Clalit Health Services members aged 6–17 years during 2006–2011. The use of stimulant medication is growing among children in Israel. Although the overall use does not exceed the estimated prevalence of ADHD among children, the appropriateness of prescribing to the Israeli pediatric population, especially to the youngest children in class, may be questionable.
Digital technology has penetrated all aspects of modern culture, and it has been purported revolutionize education. However, a growing concern alludes to subtle adverse effects it may have on learning outcomes. The current work studied the association between problematic Internet use (PIU) and academic achievements among pre-service teacher trainee students (N=138) from two educational colleges in Israel. A significant interaction effect for PIU and gender was observed on students’ grades, while holding four demographic variables as covariate. These results indicate an underlying behavioral phenomenon with unique relevance in an educational context.
Mahajnah, M., R. Sharkia, N. Shorbaji, R. Terkel-Dawer, and N. Zelnik. “P173 – 2561: The Clinical Profile of ADHD in Israel – Impact of Ethnic and Social Diversities.” European Journal of Paediatric Neurology 19, sup. 1 (2015): S142 ff.
The diagnosis of ADHD relies mostly on clinical observation and employment of standard questionnaires and checklist batteries which are highly susceptible to human factors. In this study we searched for differences in the clinical profile of children with ADHD in both the Arab and Jewish sectors in Israel which might be influenced by cultural and social background.
Data of children aged 7–17 years diagnosed with ADHD between 2010 and 2013 in two ADHD clinics in northern Israel was analyzed. The diagnosis of ADHD was based on clinical evaluation and fulfillment of the DSM IV criteria and aided by both the Teacher and Parent Conners Rating Scales. Children with autism and intellectual disabilities were excluded.
Out of 823 patients – 516 (62.7%) were Jewish and 307 (37.3%) were Arabs. The distributions of the ADHD subtypes were similar in both populations. Learning disabilities (LD) and psychiatric comorbidities (behavioral difficulties and anxiety) were reported more frequently in the Jewish population (49% vs. 41% for LD, 15.7% vs. 12.8% for behavioral difficulties and 27.0% vs. 1.0% for anxiety p<0.05). Patients from the Jewish sector were primarily treated with long-acting methylphenidate formulations while patients from the Arab sector were treated primarily with short acting methylphenidate (p<0.05). The most commonly reported adverse effects were anorexia, headache, insomnia and rebound effect and were more frequently reported in the Jewish population (42.0% vs. 18.0% P<0.05).
This study demonstrates that while the biological nature of ADHD and its subtypes are similar in these two populations, learning disabilities, psychiatric co morbidities, employment of long-acting MPH formulations and complaints of side-effects were more prevalent in patients from the Jewish sectors. We presume that these differences are related to cultural and socioeconomic factors and the physician should take them into consideration when treating patients with ADHD.